ACE and atrial fibrillation: Regarding ACE inhibitors/AT antagonists – like beta‐blockers – new, well‐designed trials are needed to specifically evaluate patients with AF and HF, not just dichotomously, that also break down and categorize AF according to type (paroxysmal vs. permanent) and duration.